STTCOMP IMU, TA Long.
IMUGENE LTD
biotech
SP 0.023
Market Cap $68 mil
Cash $12 mil
Imugene Limited (IMU) is an Australian immuno-oncology focused Biopharmaceutical
Company developing HER2 + ve gastric and breast cancer vaccines. The Group s
lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates
a polyclonal antibody response to HER2/neu.
ascending triangle breakout looming perhaps
volume decreasing during formation
initial target .034
also been a lot of orders around and over $100,000 recently
and looking good on the monthly too
- Forums
- ASX - Short Term Trading
- XAO
- Short Term Trading Week Starting: 5 Mar
Short Term Trading Week Starting: 5 Mar, page-144
-
- There are more pages in this discussion • 158 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XAO (ASX) to my watchlist
(20min delay)
|
|||||
Last
8,602.7 |
Change
51.500(0.60%) |
Mkt cap ! n/a |
Open | High | Low |
8,551.9 | 8,611.6 | 8,551.9 |
Featured News
XAO (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online